Insider · CIK 0001592494
Gillian Munson
Files at PHR (Phreesia, Inc.), DUOL (Duolingo, Inc.), VMEO (Vimeo, Inc.). First filing Mar 21, 2025, latest Mar 21, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DUOL: Duolingo, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Duolingo, Inc. | $1.6M 5,000 shares | -59% | +37% from low-31% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | PHR Phreesia, Inc. | AGrant or award Common Stock | +6,700 | $27.61 | $185k | 44,174 | Jun 27, 2025 |
| Jun 11, 2025 | DUOL Duolingo, Inc. | AGrant or award Class A Common Stock | +379 | $0.00 | $0 | 3,909 | Jun 18, 2025 |
| Apr 30, 2025 | PHR Phreesia, Inc. | AGrant or award Common Stock | +400 | $24.96 | $9,984 | 37,474 | May 2, 2025 |
| Apr 4, 2025 | VMEO Vimeo, Inc. | FTax withholding Common Stock | -139,986 | $4.75 | $665k | 847,472 | Apr 8, 2025 |
| Mar 20, 2025 | DUOL Duolingo, Inc. | MOption exercise Class A Common Stock10b5-1 | +5,000 | $8.15 | $41k | 8,530 | Mar 21, 2025 |
| Mar 20, 2025 | DUOL Duolingo, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -5,000 | $310.00 | $1.6M | 3,530 | Mar 21, 2025 |
| Mar 20, 2025 | DUOL Duolingo, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 20,000 | Mar 21, 2025 |
| Oct 31, 2024 | PHR Phreesia, Inc. | AGrant or award Common Stock | +546 | $18.29 | $9,986 | 36,723 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.